Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.19 +0.00 (+0.00%)
As of: Oct 5, 2026 · 3:45 PM EDT

Drugs Made In America Acquisition (DMII) Non-Current Assets (2024 - 2026)

Updated

Drugs Made In America Acquisition (DMII) reported Non-Current Assets of $513.88 million for Q2 2026.

Analysis

Drugs Made In America Acquisition (DMII) Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Drugs Made In America Acquisition posted Non-Current Assets of $504.93 million.

  • By year, Non-Current Assets came in at $78,449 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 BlackRock 164.13 Bn 110.49 Bn - -
2 Spdr Gold Trust 133.82 Bn -424.18 Bn - -
3 Blackstone 84.08 Bn 79.01 Bn - -
4 Brookfield 82.97 Bn -82.41 Bn 4.47 Bn -
5 Kkr 81.05 Bn 47.53 Bn - -
6 Brookfield Asset Management 71.64 Bn 67.88 Bn - -
7 Apollo Global Management 65.67 Bn 3.35 Bn 10.56 Bn -
8 Wheaton Precious Metals 61.89 Bn 57.32 Bn 687.86 Mn 12.03 Bn
9 Franco Nevada 46.13 Bn 43.49 Bn 451.00 Mn 7.53 Bn
10 Drugs Made In America Acquisition 649.10 Mn 649.10 Mn - 513.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 513.88 Mn
Dec 31, 2025 504.93 Mn
Sep 30, 2025 500.11 Mn
Dec 31, 2024 78,449.00
API Access

Drugs Made In America Acquisition Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=DMII&period=max&api_key=YOUR_API_KEY